| Enrichment of autologous fat grafts with ex-vivo expanded adipose tissue-derived stem cells for graft survival: a randomised placebo-controlled trial SFT Kølle, A Fischer-Nielsen, AB Mathiasen, JJ Elberg, RS Oliveri, ... The Lancet 382 (9898), 1113-1120, 2013 | 609 | 2013 |
| Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction J Lønborg, N Vejlstrup, H Kelbæk, HE Bøtker, WY Kim, AB Mathiasen, ... European heart journal 33 (12), 1491-1499, 2012 | 609 | 2012 |
| Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial) AB Mathiasen, AA Qayyum, E Jørgensen, S Helqvist, A Fischer-Nielsen, ... European heart journal 36 (27), 1744-1753, 2015 | 350 | 2015 |
| Adipose-derived mesenchymal stromal cells for chronic myocardial ischemia (MyStromalCell Trial): study design AA Qayyum, M Haack-Sørensen, AB Mathiasen, E Jørgensen, A Ekblond, ... Regenerative medicine 7 (3), 421-428, 2012 | 144 | 2012 |
| Pooled human platelet lysate versus fetal bovine serum—investigating the proliferation rate, chromosome stability and angiogenic potential of human adipose tissue-derived stem … SFT Kølle, RS Oliveri, PV Glovinski, M Kirchhoff, AB Mathiasen, JJ Elberg, ... Cytotherapy 15 (9), 1086-1097, 2013 | 122 | 2013 |
| Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in … AB Mathiasen, E Jørgensen, AA Qayyum, M Haack-Sørensen, A Ekblond, ... American heart journal 164 (3), 285-291, 2012 | 103 | 2012 |
| Bone marrow‐derived mesenchymal stromal cell treatment in patients with ischaemic heart failure: final 4‐year follow‐up of the MSC‐HF trial AB Mathiasen, AA Qayyum, E Jørgensen, S Helqvist, KF Kofoed, ... European journal of heart failure 22 (5), 884-892, 2020 | 100 | 2020 |
| Long term molecular responses in a cohort of Danish patients with essential thrombocythemia, polycythemia vera and myelofibrosis treated with recombinant interferon alpha TS Larsen, KF Iversen, E Hansen, AB Mathiasen, C Marcher, ... Leukemia research 37 (9), 1041-1045, 2013 | 97 | 2013 |
| Cryopreserved off-the-shelf allogeneic adipose-derived stromal cells for therapy in patients with ischemic heart disease and heart failure—a safety study J Kastrup, M Haack-Sørensen, M Juhl, R Harary Søndergaard, B Follin, ... Stem Cells Translational Medicine 6 (11), 1963-1971, 2017 | 95 | 2017 |
| Mesenchymal stromal cell derived endothelial progenitor treatment in patients with refractory angina T Friis, M Haack-Sørensen, AB Mathiasen, RS Ripa, US Kristoffersen, ... Scandinavian Cardiovascular Journal 45 (3), 161-168, 2011 | 92 | 2011 |
| Left atrial volume and function in patients following ST elevation myocardial infarction and the association with clinical outcome: a cardiovascular magnetic resonance study JT Lønborg, T Engstrøm, JE Møller, KA Ahtarovski, H Kelbæk, ... European Heart Journal–Cardiovascular Imaging 14 (2), 118-127, 2013 | 91 | 2013 |
| Autotransplantation of mesenchymal stromal cells from bone-marrow to heart in patients with severe stable coronary artery disease and refractory angina—final 3-year follow-up AB Mathiasen, M Haack-Sørensen, E Jørgensen, J Kastrup International journal of cardiology 170 (2), 246-251, 2013 | 86 | 2013 |
| Mesenchymal stromal cells for cardiovascular repair: current status and future challenges AB Mathiasen, M Haack-Sørensen, J Kastrup Future Cardiology 5 (6), 605-617, 2009 | 85 | 2009 |
| The influence of statin treatment on the inflammatory biomarkers YKL-40 and HsCRP in patients with stable coronary artery disease ND Mygind, MJ Harutyunyan, AB Mathiasen, RS Ripa, JJ Thune, ... Inflammation research 60, 281-287, 2011 | 71 | 2011 |
| Direct intramyocardial mesenchymal stromal cell injections in patients with severe refractory angina: one-year follow-up M Haack-Sørensen, T Friis, AB Mathiasen, E Jørgensen, L Hansen, ... Cell transplantation 22 (3), 521-528, 2013 | 67 | 2013 |
| Plasma YKL-40 in relation to the degree of coronary artery disease in patients with stable ischemic heart disease AB Mathiasen, MJ Harutyunyan, E Jørgensen, S Helqvist, R Ripa, ... Scandinavian journal of clinical and laboratory investigation 71 (5), 439-447, 2011 | 48 | 2011 |
| Adipose-derived stromal cells for treatment of patients with chronic ischemic heart disease (MyStromalCell trial): a randomized placebo-controlled study AA Qayyum, AB Mathiasen, ND Mygind, JT Kühl, E Jørgensen, S Helqvist, ... Stem cells international 2017, 2017 | 44 | 2017 |
| Rationale and design of the European multicentre study on Stem Cell therapy in IschEmic Non‐treatable Cardiac diseasE (SCIENCE) C Paitazoglou, MW Bergmann, B Vrtovec, SAJ Chamuleau, ... European Journal of Heart Failure 21 (8), 1032-1041, 2019 | 43 | 2019 |
| Myocardial area at risk and salvage measured by T2-weighted cardiovascular magnetic resonance: reproducibility and comparison of two T2-weighted protocols J Lønborg, N Vejlstrup, AB Mathiasen, C Thomsen, JS Jensen, ... Journal of Cardiovascular Magnetic Resonance 13 (1), 50, 2011 | 42 | 2011 |
| High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR trial MJ Harutyunyan, AB Mathiasen, P Winkel, JP Gøtze, JF Hansen, ... Scandinavian journal of clinical and laboratory investigation 71 (1), 52-62, 2011 | 41 | 2011 |
Peter ClemmensenUniversity Heart and Vascular Center Hamburg, University Clinic Hamburg-Eppendorf (UKE)Verified email at docclemme.dk
